Finance
Lilly’s Weight Loss Sets High Bar for Obesity Drug Race
Image via Bloomberg
Article Summary
50 words
Sam Fazeli, Director of Research for Global Industries and Senior Pharmaceuticals Analyst for Bloomberg Intelligence, joined Bloomberg's Scarlett Fu and Paul Sweeney to discuss the gains and losses in the GLP1 market. (Source: Bloomberg) This story was reported by Bloomberg. For more Finance news in Kenya, stay tuned to Masaa.
Continue Reading
Full story on Bloomberg
🔗 Clicking will take you to www.bloomberg.com



